Oral Cannabidiol for Opioid Withdrawal

NCT04238754 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Opioid Withdrawal
Opioid Craving
Opioid Use Disorder

Interventions

DRUG: Epidiolex
DRUG: Placebo

Sponsor

Johns Hopkins University

Collaborators

[object Object]